Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-20-007898
Filing Date
2020-03-30
Accepted
2020-03-30 14:12:47
Documents
1
Group Members
ALROV HOLDINGS TECHNOLOGIES LTD.ALROV PROPERTIES & LODGINGS LTD.TECHNOROV HOLDINGS (1993) LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G ea120173-sc13galfred_prota.htm SC 13G 108538
  Complete submission text file 0001213900-20-007898.txt   110176
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 20756061
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ALROV TOWER 46 ROTHSCHILD BLVD TEL AVIV L3 66883
Business Address
Akirov Alfred (Filed by) CIK: 0001434514 (see all company filings)

Type: SC 13G